Co-Managed With Uptown Eye Specialists

Glaucoma and Dry Eye

The drops that protect your optic nerve from glaucoma can quietly damage the surface of your eye. Preservatives, especially BAK, drive inflammation in the very tissues that produce tears. UDEI works alongside the glaucoma team at Uptown Eye Specialists so your sight is protected — and your eyes still feel like your own.

Book Assessment

40-60%

of glaucoma patients
have ocular surface disease

BAK

the preservative in most
glaucoma drops drives OSD

Co-Rx

managed jointly with
Uptown Eye glaucoma team

Reversible

drop-induced OSD often
improves with regimen change

About this condition

Why Glaucoma Therapy Causes Dry Eye

Topical glaucoma drops are extraordinary at preserving the optic nerve — but the fluid you put in your eye every day reaches more than just the drainage angle. Most glaucoma drops contain benzalkonium chloride (BAK), a preservative that kills bacteria in the bottle and, with chronic use, damages the cells of the cornea, conjunctiva, and lid margin at the same time.

The result is a low-grade inflammatory state on the ocular surface: goblet cells drop in number, tear film stability breaks down, and the Meibomian glands that produce the tear film’s oil layer start to fail. Patients describe it as burning drops, grittiness between doses, redness, and sometimes blurry vision that fluctuates with each blink — often blamed on the glaucoma itself, when the drops are actually doing it.

Estimates suggest 40 to 60% of treated glaucoma patients meet the criteria for ocular surface disease. The number climbs with the number of bottles, the years on therapy, and the total daily BAK dose. Yet the surface is rarely examined in a typical glaucoma visit, because pressure is the endpoint — and most patients assume the burning is just “part of having glaucoma.” It isn’t.

Why this matters for your glaucoma

When drops burn, patients don’t take them. Studies consistently show that the more irritating the regimen, the lower the adherence — which means pressure rises silently between visits, and the risk of optic nerve progression rises with it. A more comfortable regimen isn’t cosmetic: it protects sight.

The surface itself is repairable. Patients who switch to preservative-free formulations, consolidate to fixed-dose combinations, or move to SLT or minimally-invasive glaucoma surgery often see their surface recover within weeks to months. UDEI co-ordinates with your glaucoma specialist at Uptown Eye so the regimen change is driven by pressure targets as well as surface health — not one at the expense of the other.

Symptoms

Symptoms That May Be Your Drops, Not Your Glaucoma

Glaucoma-related ocular surface disease usually creeps in after months or years on therapy. If any of these sound familiar, your drops may be part of the picture:

A burning or stinging sensation immediately after each drop — lasting several minutes
Persistently red eyes, particularly along the lid margin
A gritty or foreign-body sensation between drops
Blurred vision that clears on blinking, rather than being a steady loss of sight
Skin changes on the eyelids — tightening, darkening, or deepening of the upper lid sulcus (often called “prostaglandin-associated periorbitopathy”)
Increased tearing in the wind or outdoors
Fear or reluctance about instilling your drops, even when you know you should

If any of the above are part of your daily experience, tell us at your assessment. These are not things you simply “live with” for glaucoma — they are signals we can act on alongside your glaucoma specialist.

Diagnosis

How We Assess Glaucoma-Related Dry Eye

A UDEI assessment for a glaucoma patient is deliberately different from a routine glaucoma visit. We look at what the drops have done, not just at pressure — and we coordinate with your Uptown Eye glaucoma specialist throughout.

Drop History & Surface Symptoms

We map every bottle you’ve been on — which drops, how long, how many times a day, whether they contain BAK — alongside your surface symptoms. This timeline often shows exactly when the surface started to fail.

Meibography & Lid Margin Imaging

Chronic drop use often damages the Meibomian glands themselves — not just the tear film. Infrared meibography lets us see which glands are still full-length, which are truncating, and which are dropping out. In patients on long-term BAK-preserved drops, the pattern of gland loss is often far more pronounced than a routine exam suggests.

These images do two jobs: they tell us how aggressive the surface disease has become, and they give your glaucoma specialist objective data for a regimen-change conversation — one backed by structure, not just symptoms.

Tear Film & Inflammation Testing

We measure tear osmolarity, inflammatory markers, and tear break-up time. In drop-induced OSD, the hallmarks are elevated osmolarity, raised MMP-9 inflammation, and a short, unstable tear film — all of which can drive fluctuating vision between doses.

Conjunctival & Corneal Staining

We use vital dyes to highlight areas where the surface is compromised — fine staining on the cornea, redness and injection of the conjunctiva, and damage to the goblet cells that produce the mucin layer of the tear film. These findings often correlate directly with how many BAK-preserved drops a patient is on.

Joint Plan With Your Glaucoma Specialist

Findings are shared back with your glaucoma specialist — often at Uptown Eye Specialists — so decisions about preservative-free formulations, regimen consolidation, SLT, or minimally-invasive glaucoma surgery can be made with complete surface information on the table. Pressure control and surface comfort are managed as one problem, not two.

Treatment options

How We Treat Glaucoma-Related Dry Eye

Treatment begins with one question: can we reduce the preservative burden on your eye without giving up pressure control? In most cases the answer is yes, and it shapes everything that follows.

Alongside the regimen-change conversation with your glaucoma specialist, we treat the surface damage directly — calming inflammation, restoring lipid layer quality, and rebuilding the tear film so your drops (whichever ones you end up on) are better tolerated.

Preservative-Free Regimen Review

Working with your glaucoma specialist to identify where preservative-free bottles, fixed-dose combinations, or different molecules can replace the current BAK load on your eye.

First-line, co-managed

UltraView DEL™ (IPL)

Intense pulsed light therapy to calm eyelid inflammation and support Meibomian gland function for patients with inflammatory ocular surface disease.

Inflammatory OSD
Learn about UltraView DEL →

Punctal Occlusion

Temporary or permanent occlusion of the tear drainage points keeps natural tears (and any non-preserved drops) on the eye longer. Especially useful for patients with aqueous deficiency from long-term drop use.

Aqueous-deficient OSD

Anti-Inflammatory Drops (Preservative-Free)

Short courses of preservative-free corticosteroid drops, or longer-term immunomodulatory drops, calm the inflammation that drop-induced OSD drives. Chosen specifically to avoid adding more preservative burden.

Moderate to severe OSD

Lid Hygiene & ZoHx

Professional eyelid cleaning to remove inflammatory debris and biofilm that interfere with Meibomian gland recovery in long-term drop users.

Surface maintenance
Learn about ZoHx →

Advanced Rescue Therapy

For severe, long-standing drop-induced surface disease we can escalate to autologous serum tears or amniotic membrane to help the surface heal. Reserved for patients who haven’t responded to first-line measures.

Severe / refractory

Most patients see meaningful improvement once their regimen is simplified and the surface is actively treated. Pressure control stays intact — we make sure of it, together with your glaucoma specialist.

Connected care

Glaucoma, Dry Eye, and the Team Around You

Glaucoma is never just about pressure. Your care moves between several specialists in the UVG family — each one focused on a different piece of the same eye:

Your glaucoma specialist. Pressure targets, field progression, and regimen decisions stay with the glaucoma team at Uptown Eye Specialists. UDEI feeds back surface data so those decisions are fully informed.

Cataract surgery with glaucoma on board. A healthy surface matters for accurate biometry and smooth recovery. UDEI optimises the surface pre-operatively so Uptown Eye Specialists can operate on the best eye possible — especially important when combined cataract and MIGS procedures are planned.

Daily-use products and eyewear. U Optical can fit moisture-chamber eyewear for patients with severe surface disease, and U Shoppe stocks the preservative-free lubricants and lid hygiene products we actually recommend.

Common questions

Frequently Asked Questions

Most glaucoma drops contain benzalkonium chloride (BAK) as a preservative. Over years of daily use, BAK inflames the conjunctival goblet cells and the Meibomian glands, disrupts the tear film, and damages the surface of the cornea. It’s a predictable side effect of chronic preserved therapy — not a coincidence.

Burning immediately after drop instillation is one of the most common markers of preservative-related surface disease. It’s common — but not something you have to accept. Preservative-free formulations and fixed-dose combinations can dramatically reduce both the burn and the long-term damage.

Not on your own. Glaucoma therapy protects the optic nerve, and stopping drops without a plan can put your sight at risk. What we can do is work with your glaucoma specialist to find a regimen that controls pressure and respects the surface — often by switching molecules, moving to preservative-free versions, or considering SLT or MIGS.

BAK (benzalkonium chloride) is the preservative used in most multi-dose glaucoma drops. It keeps the bottle sterile, but with daily lifelong use it also damages the cells of the cornea, conjunctiva, and Meibomian glands. The higher your total daily BAK dose — more bottles, more drops per bottle — the more surface disease builds up.

Indirectly, yes. Selective laser trabeculoplasty (SLT) and minimally-invasive glaucoma surgery (MIGS) can reduce or eliminate the number of drops required, which reduces preservative exposure. They’re surgical decisions made by your glaucoma specialist — but when surface disease is significant, they’re worth discussing.

Yes, and their availability has improved substantially in recent years. Preservative-free prostaglandin analogues, beta-blockers, and fixed-dose combinations now exist. Whether they’re the right choice depends on your pressure targets, response to current therapy, and insurance coverage — all part of the conversation with your glaucoma specialist.

Most patients notice symptoms improving within weeks of a regimen change, with objective surface findings (staining, tear break-up time, osmolarity) improving over one to three months. Some long-standing damage — particularly Meibomian gland dropout — may not fully reverse, but symptoms and tear film stability usually do.

No. Glaucoma management is led by your glaucoma specialist — for most of our co-managed patients, that’s the team at Uptown Eye Specialists. UDEI is responsible for the surface: diagnosing drop-induced dry eye, treating the inflammation, and sharing findings with your glaucoma specialist so regimen decisions are fully informed.

OHIP covers standard ophthalmic examination and drop-related dry eye assessment where medically indicated. In-office treatments (IPL, ZoHx, punctal occlusion) and advanced diagnostics (osmolarity, meibography) are specialised services not covered. Extended health insurance often covers some prescription drops and in-office procedures. We provide itemised receipts for insurance claims.

Refer any glaucoma patient who describes chronic burning, grittiness, or redness with their drops; any patient on two or more BAK-containing bottles; any patient whose adherence is slipping because of surface symptoms; and any patient approaching cataract surgery with visible lid margin disease or staining. Early referral is easier to resolve than established, long-standing surface damage.

Co-managed, not compromised

Protect your sight and your comfort.

If your glaucoma drops burn, blur, or make you dread every dose, that’s a signal — not a sentence. A UDEI assessment, shared with your Uptown Eye glaucoma specialist, is the first step toward a regimen that protects your optic nerve and respects the surface of your eye.